Influence of the Anesthetic Regimen during the Endovascular Treatment of Intracranial Proximal Occlusions with a Large Infarct Core: A Post Hoc Analysis of the LASTE Trial Data

Read full text
Authors: Gaultier Marnat, Bertrand Lapergue, Julien Labreuche, Vincent Costalat, Hugues de Courson, Russell Chabanne, Liesjet E. H. van Dokkum, Christophe Cognard, Jean‐François Albucher, Hilde Hénon, Nasreddine Nouri, Benjamin Gory
+19 more Sébastien Richard, Grégoire Boulouis, Mariam Annan, Michel Piotin, Michaël Obadia, Romain Bourcier, Vincent L’Allinec, Omer Eker, Olivier N. Naggara, Stéphane Velasco, Frédéric Clarençon, Louis Delamarre, B. Guillon, Guillaume Turc, David S. Liebeskind, Tudor G. Jovin, Igor Sibon, Caroline Arquizan, on behalf of the LASTE Trial Investigators
Cited by: 0
References: 23

Abstract

Background and Purpose: The optimal anesthetic regimen for the endovascular treatment (EVT) of stroke due to large vessel occlusion remains unclear. Patients with large infarct core on initial imaging constitute a specific subpopulation. The aim of this study was to investigate the impact of the anesthesia type during EVT on outcomes in this subpopulation. Materials and Methods: Data were extracted from the multicenter, randomized, controlled LASTE trial (n = 30 centers in France and Spain) that compared EVT plus best medical treatment versus best medical treatment alone in patients with large infarct core (ASPECTS = 0-5). In this post-hoc analysis, only patients who underwent EVT were included. Two study groups were defined: general anesthesia (GA), and conscious sedation and/or local anesthesia (CS-LA). The primary endpoint was the functional outcome, assessed with the modified Rankin Scale (mRS) at 3 months. Secondary endpoints included early neurological status, infarct extension at day 1, symptomatic intracranial hemorrhage, and mortality. Endpoints were investigated using univariate and multivariate analyses adjusted for pre-specified confounders. Results: For this post-hoc analysis, 159 patients were included: 45 in the GA group and 114 in the CS-LA group. The functional outcome at 3 months was not different between groups: median mRS score = 5 (IQR: 3-6) in the GA and 4 (IQR: 3-6) in the CS-LA group (adjusted OR = 0.78; 95% CI 0.52 - 1.18). However, in the GA group, the National Institutes of Health Stroke Scale score significantly worsened between admission and day 1 [mean difference= -3.8 (-6.6 to -1.0), p=0.007], infarct volume extension was more severe [mean difference: -26.5 ml (-50.2 to -2.9), p=0.028], and parenchymal hematoma was more frequently detected. Between-group differences in early neurological improvement, symptomatic intracranial hemorrhage, and mortality were not significant. Conclusion: In this post-hoc analysis of the LASTE trial data, we detected potential signals of a GA detrimental effect in patients with large infarct core on baseline imaging. Larger studies are necessary to confirm this finding.

Fields of Study & Subjects

Acute Ischemic Stroke Management Intracranial Aneurysms: Treatment and Complications Cerebrovascular and Carotid Artery Diseases

Publication details

Journal / source
American Journal of Neuroradiology
Volume
47
Issue
7
Pages
1846–1852
Publication date
10 February 2026
Language
EN